We compared the outcome of 25 untreated pregnancies among women with recurrent
miscarriage (RM) at< 12 weeks' gestation who were heterozygous for factor V Leiden with …

The role of Factor V Leiden (FVL) mutation in recurrent miscarriages has been disputed. It
has been hypothesized that FVL mutation in patients with recurrent miscarriages is treatable …

BACKGROUND: Some cases of recurrent miscarriage and later pregnancy complications
have a thrombotic basis. Factor V Leiden is a common thrombophilic mutation. METHODS …

The Leiden mutation is a recent discovery. It is the main cause of inherited thrombophilia
and has been found in 20–60% of deep vein thrombosis cases. More recently it has been …

The purpose of this study was to determine if there is an increased prevalence of the
thrombophilic genetic mutant factor V Leiden in patients with recurrent miscarriage …

The purpose of this study was to determine the prevalence and analysis of factor V Leiden
G1691A (Leiden mutation) among Sudanese women with recurrent abortions; further, to …

Objective: To determine the association of factor V Leiden mutation with recurrent pregnancy
loss. Methods: The case-control study was conducted at the Department of Haematology …

Objective To observe the effect of thrombophylaxis on pregnancy in women with a history of
unexplained recurrent pregnancy loss also carrying the factor V Leiden mutation. Methods …

STUDY QUESTION What is the time to conception in a cohort of women with unexplained
recurrent miscarriage (RM). SUMMARY ANSWER Median time to conception in women …

Although recurrent pregnancy loss is rare, it is a major health problem. Fewer than 50% of
cases have definitive causes. Thrombophilias such as factor V Leiden mutation may be …